Skip to main content
. 2011 Sep;32(8):1373–1374. doi: 10.3174/ajnr.A2619

Fig 1.

Fig 1.

Schematic illustration showing the proposed mechanism of trastuzumab. Herceptin is a monoclonal antibody that binds to the extracellular portion of the HER2 gene, preventing dimerization and the cascade that leads to the expression of growth factors. It also induces apoptosis through antibody-dependent cellular cytotoxicity. Illustration by Carolyn Nowak.